生物製藥細胞培養市場規模、佔有率和成長分析：按產品類型、細胞類型、培養類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球生物製藥細胞培養市場價值為 263 億美元，預計到 2033 年將成長至 630.4 億美元，而 2025 年為 289.8 億美元，預測期（2026-2033 年）的複合年成長率為 10.2%。

全球生物製藥細胞培養市場的發展動力源自於對複雜生物製藥和個人化療法日益成長的需求，而這些都需要先進的細胞生產系統。該市場涵蓋細胞增殖、培養基和飼養層開發、生物反應器以及單株抗體、重組蛋白和細胞療法生產所需的耗材。關鍵成長要素包括向一次性技術和製程整合的轉變，這有助於提高產能、最大限度地降低污染風險並增強擴充性。此外，人工智慧驅動的自動化技術的應用進一步提高了製程效率，降低了變異性，並透過預測控制和即時監控提高了產量。透過實施可互通的平台和自動化解決方案，相關人員可以有效地簡化工作流程、最佳化資源並加速研發。這為因應市場動態和新興醫療需求創造了新的機會和韌性。

全球生物製藥細胞培養市場的成長要素

全球生物製藥細胞培養市場的主要促進因素之一是對單株抗體和治療性蛋白質日益成長的需求。隨著慢性病盛行率的持續上升，製藥公司加大了對生物製藥研發的投資，而先進的細胞培養技術是其生產的關鍵。生物製藥產品線的擴展以及對更高效、更經濟的生產流程的需求，進一步推動了人們對創新治療方法的興趣。此外，細胞培養技術的進步，例如生物反應器和自動化系統的引入，提高了生產效率和擴充性，從而進一步促進了市場成長。

全球生物製藥細胞培養市場的限制因素

全球生物製藥細胞培養市場的主要限制因素之一是先進細胞培養技術和試劑的高成本。開發、維護和擴大細胞培養規模的成本可能非常高，尤其對於中小企業而言更是如此。此外，嚴格的監管要求和繁瑣的驗證流程會進一步增加新產品上市的經濟負擔和複雜性。這種經濟挑戰可能會阻礙創新，限制小規模企業的進入，最終影響整個生物製藥細胞培養產業的成長。

全球生物製藥細胞培養市場趨勢

全球生物製藥細胞培養市場正呈現出顯著的自動化和數位化整合趨勢，相關人員日益重視流程的一致性和可擴展性。機器人、線上感測器和先進數據平台的整合正在變革細胞培養工作流程，簡化操作並最大限度地減少人工干預。這種技術變革提高了整個研發和生產階段的流程透明度。供應商和終端用戶都致力於開發可互通的解決方案，以實現遠端監控、預測性維護和即時調整，最終提高營運效率。這些進步也有助於加快技術從實驗室到商業生產基地的轉移，同時確保符合監管標準。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球生物製藥細胞培養市場規模：依產品類型分類

• 培養基
  • 無血清培養基
  • 常規培養基
  • 特殊培養基
  • 幹細胞培養基
  • 化學成分明確的培養基
  • 其他
• 試劑和補充劑
  • 生長因子和細胞激素
  • 血清
  • 緩衝液和鹽
  • 抗生素和抗真菌藥物
  • 細胞分散試劑
  • 其他
• 細胞培養系統和耗材
  • 生物反應器
  • 細胞培養容器
  • 過濾系統
  • 一次組裝
  • 細胞培養袋
  • 其他
• 服務
  • 培養基製備服務
  • 細胞株開發服務
  • 流程開發服務
  • 分析和測試服務

全球生物製藥細胞培養市場規模：依細胞類型分類

• 哺乳動物細胞
  • CHO細胞
  • HEK 293細胞
  • BHK 細胞
  • Vero細胞
  • NS0 和 SP2/0 細胞
  • 其他
• 微生物細胞
  • 細菌細胞
  • 酵母菌細胞
• 昆蟲細胞
• 幹細胞

全球生物製藥細胞培養市場規模：依培養類型分類

• 懸浮培養
• 黏附培養
• 3D細胞培養

全球生物製藥細胞培養市場規模：依應用領域分類

• 單株抗體生產
• 疫苗生產
• 重組蛋白生產
• 細胞及基因治療製造
• 藥物篩檢和開發
• 毒性測試
• 組織工程與再生醫學
• 生物相似藥生產

全球生物製藥細胞培養市場規模：依最終用戶分類

• 生物製藥公司
• 合約研發生產組織（CDMO）
• 學術研究機構
• 生技公司
• 其他

全球生物製藥細胞培養市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Sartorius AG
• Lonza Group
• Corning Incorporated
• FUJIFILM Holdings Corporation
• Eppendorf SE
• Avantor
• Repligen Corporation
• Cytiva
• Getinge AB
• Becton Dickinson and Company
• Agilent Technologies
• HiMedia Laboratories
• Takara Bio Inc.
• PromoCell GmbH
• CellGenix GmbH
• Miltenyi Biotec
• Sino Biological Inc.

結論與建議

Global Biopharmaceutical Cell Culture Market size was valued at USD 26.3 Billion in 2024 and is poised to grow from USD 28.98 Billion in 2025 to USD 63.04 Billion by 2033, growing at a CAGR of 10.2% during the forecast period (2026-2033).

The global biopharmaceutical cell culture market is driven by increasing demand for complex biologics and personalized therapies, necessitating advanced cell production systems. This market encompasses cell expansion, media and feed development, bioreactors, and consumables essential for generating monoclonal antibodies, recombinant proteins, and cell therapies. Significant growth factors include the shift towards single-use technologies and process intensification, which facilitate capacity expansion, minimize contamination risks, and enhance scalability. The deployment of AI-driven automation further boosts process efficiency through predictive control and real-time monitoring, thereby reducing variability and increasing throughput. By embracing interoperable platforms and automated solutions, stakeholders effectively streamline workflows, optimize resources, and accelerate development, unlocking new opportunities and resilience in response to market dynamics and emerging healthcare demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceutical Cell Culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceutical Cell Culture Market Segments Analysis

Global biopharmaceutical cell culture market is segmented by product type, cell type, culture type, application, end user and region. Based on product type, the market is segmented into Media, Reagents and Supplements, Cell Culture Systems and Consumables and Services. Based on cell type, the market is segmented into Mammalian Cells, Microbial Cells, Insect Cells and Stem Cells. Based on culture type, the market is segmented into Suspension Culture, Adherent Culture and 3D Cell Culture. Based on application, the market is segmented into Monoclonal Antibody Production, Vaccine Production, Recombinant Protein Production, Cell and Gene Therapy Manufacturing, Drug Screening and Development, Toxicity Testing, Tissue Engineering and Regenerative Medicine and Biosimilar Production. Based on end user, the market is segmented into Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), Academic and Research Institutes, Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceutical Cell Culture Market

One of the key market drivers for the global biopharmaceutical cell culture market is the increasing demand for monoclonal antibodies and therapeutic proteins. As the prevalence of chronic diseases continues to rise, pharmaceutical companies are increasingly investing in the development of biologics, which rely heavily on advanced cell culture techniques for production. This growing focus on innovative therapies is further fueled by the expanding pipeline of biopharmaceuticals and the need for more efficient and cost-effective manufacturing processes. Additionally, advancements in cell culture technologies, such as the use of bioreactors and automated systems, are enhancing productivity and scalability, further propelling market growth.

Restraints in the Global Biopharmaceutical Cell Culture Market

One key market restraint for the global biopharmaceutical cell culture market is the high cost associated with advanced cell culture technologies and reagents. The expenses related to the development, maintenance, and scaling of cell culture operations can be prohibitive, especially for small and medium-sized enterprises. Additionally, stringent regulatory requirements and the need for extensive validation processes can further increase the financial burden and complexity of bringing new products to market. This economic challenge may hinder innovation and limit accessibility for smaller players, ultimately affecting the overall growth of the biopharmaceutical cell culture sector.

Market Trends of the Global Biopharmaceutical Cell Culture Market

The Global Biopharmaceutical Cell Culture market is experiencing a significant trend towards automation and digital integration, as industry stakeholders increasingly emphasize the need for consistent and scalable processes. The integration of robotics, inline sensors, and advanced data platforms is transforming cell culture workflows, streamlining operations, and minimizing manual interventions. This technological shift enhances process transparency throughout development and production phases. Both vendors and end-users are focusing on interoperable solutions that enable remote monitoring, predictive maintenance, and real-time adjustments, ultimately driving operational efficiency. Such advancements also facilitate quicker technology transfers from laboratories to commercial manufacturing sites, while ensuring adherence to regulatory standards.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Biopharmaceutical Cell Culture Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Media
  • Serum-free Media
  • Classical Media
  • Specialty Media
  • Stem Cell Culture Media
  • Chemically Defined Media
  • Others
• Reagents and Supplements
  • Growth Factors and Cytokines
  • Sera
  • Buffers and Salts
  • Antibiotics and Antimycotics
  • Cell Dissociation Reagents
  • Others
• Cell Culture Systems and Consumables
  • Bioreactors
  • Cell Culture Vessels
  • Filtration Systems
  • Single-use Assemblies
  • Cell Culture Bags
  • Others
• Services
  • Media Preparation Services
  • Cell Line Development Services
  • Process Development Services
  • Analytical and Testing Services

Global Biopharmaceutical Cell Culture Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Mammalian Cells
  • CHO Cells
  • HEK 293 Cells
  • BHK Cells
  • Vero Cells
  • NS0 and SP2/0 Cells
  • Others
• Microbial Cells
  • Bacterial Cells
  • Yeast Cells
• Insect Cells
• Stem Cells

Global Biopharmaceutical Cell Culture Market Size by Culture Type & CAGR (2026-2033)

• Market Overview
• Suspension Culture
• Adherent Culture
• 3D Cell Culture

Global Biopharmaceutical Cell Culture Market Size by Application & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibody Production
• Vaccine Production
• Recombinant Protein Production
• Cell and Gene Therapy Manufacturing
• Drug Screening and Development
• Toxicity Testing
• Tissue Engineering and Regenerative Medicine
• Biosimilar Production

Global Biopharmaceutical Cell Culture Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Companies
• Contract Development and Manufacturing Organizations (CDMOs)
• Academic and Research Institutes
• Biotechnology Companies
• Others

Global Biopharmaceutical Cell Culture Market Size & CAGR (2026-2033)

• North America (Product Type, Cell Type, Culture Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Cell Type, Culture Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Cell Type, Culture Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Cell Type, Culture Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Cell Type, Culture Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellGenix GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations